Home » Topics » Briefs » Other news to note

Other news to note
RSS

Middlesex Sciences changes name

Oct. 18, 1996

Yamanouchi awaits marketing approval for new contraceptive

Oct. 11, 1996

Aldose reductase inhibitor in phase III at Fujisawa

Oct. 11, 1996

Antidiabetic agents from Yamanouchi's clinical pipeline

Oct. 11, 1996

Yamanouchi reports on GI drugs in development

Oct. 11, 1996

Gastrointestinal drugs in the pipeline at Fujisawa

Oct. 11, 1996

Renal-urologic drugs in development at Yamanouchi

Oct. 11, 1996

Three renal-urologic drugs reported in the Fujisawa product pipeline

Oct. 11, 1996

Fujisawa's antiplatelet agent in clinical trials

Oct. 11, 1996

Significant progress in cardiovascular R&D at Yamanouchi

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...